These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21117968)

  • 1. Emergence of VIM-1 metallo-β-lactamase-producing Escherichia coli in a neonatal intensive care unit.
    Papadimitriou M; Voulgari E; Ranellou K; Koemtzidou E; Lebessi E; Tsakris A
    Microb Drug Resist; 2011 Mar; 17(1):105-8. PubMed ID: 21117968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
    Nagaraj S; Chandran SP; Shamanna P; Macaden R
    Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of carbapenem-resistant Enterobacter cloacae carrying VIM-4 metallo-beta-lactamase and SHV-2a extended-spectrum beta-lactamase in a conjugative plasmid.
    Ikonomidis A; Spanakis N; Poulou A; Pournaras S; Markou F; Tsakris A
    Microb Drug Resist; 2007; 13(4):221-6. PubMed ID: 18184047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece.
    Galani I; Souli M; Mitchell N; Chryssouli Z; Giamarellou H
    Int J Antimicrob Agents; 2010 Sep; 36(3):252-4. PubMed ID: 20580536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First identification of an Escherichia coli clinical isolate producing both metallo-beta-lactamase VIM-2 and extended-spectrum beta-lactamase IBC-1.
    Galani I; Souli M; Chryssouli Z; Katsala D; Giamarellou H
    Clin Microbiol Infect; 2004 Aug; 10(8):757-60. PubMed ID: 15301681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First detection of VIM-4 metallo-β-lactamase-producing Escherichia coli in Russia.
    Shevchenko OV; Mudrak DY; Skleenova EY; Kozyreva VK; Ilina EN; Ikryannikova LN; Alexandrova IA; Sidorenko SV; Edelstein MV
    Clin Microbiol Infect; 2012 Jul; 18(7):E214-7. PubMed ID: 22487052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity.
    Göttig S; Hamprecht AG; Christ S; Kempf VA; Wichelhaus TA
    J Antimicrob Chemother; 2013 Aug; 68(8):1737-40. PubMed ID: 23557929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in Spain.
    Porres-Osante N; Azcona-Gutiérrez JM; Rojo-Bezares B; Undabeitia E; Torres C; Sáenz Y
    J Antimicrob Chemother; 2014 Jul; 69(7):1792-5. PubMed ID: 24583362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
    Ho WS; Balan G; Puthucheary S; Kong BH; Lim KT; Tan LK; Koh XP; Yeo CC; Thong KL
    Microb Drug Resist; 2012 Aug; 18(4):408-16. PubMed ID: 22394084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of carbapenems against a metallo-β-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model.
    Souli M; Konstantinidou E; Tzepi I; Tsaganos T; Pefanis A; Chryssouli Z; Galani I; Giamarellos-Bourboulis E; Giamarellou H
    J Antimicrob Chemother; 2011 Mar; 66(3):611-7. PubMed ID: 21177674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
    Zarfel G; Hoenigl M; Würstl B; Leitner E; Salzer HJ; Valentin T; Posch J; Krause R; Grisold AJ
    Clin Microbiol Infect; 2011 Nov; 17(11):E5-8. PubMed ID: 21939472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notes from the Field: Verona Integron-Encoded Metallo-Beta-Lactamase-Producing Carbapenem-Resistant Enterobacteriaceae in a Neonatal and Adult Intensive Care Unit--Kentucky, 2015.
    Yaffee AQ; Roser L; Daniels K; Humbaugh K; Brawley R; Thoroughman D; Flinchum A
    MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):190. PubMed ID: 26914726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?
    Tato M; Coque TM; Ruíz-Garbajosa P; Pintado V; Cobo J; Sader HS; Jones RN; Baquero F; Cantón R
    Clin Infect Dis; 2007 Nov; 45(9):1171-8. PubMed ID: 17918078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase.
    Mavroidi A; Miriagou V; Malli E; Stefos A; Dalekos GN; Tzouvelekis LS; Petinaki E
    Int J Antimicrob Agents; 2012 Mar; 39(3):247-50. PubMed ID: 22226650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
    Simner PJ; Zhanel GG; Pitout J; Tailor F; McCracken M; Mulvey MR; Lagacé-Wiens PR; Adam HJ; Hoban DJ;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a novel variant bla(CTX-M-3) extended spectrum beta-lactamase gene in a community-acquired Escherichia coli isolate.
    Pournaras S; Tsakris A; Ikonomidis A; Markogiannakis A; Kristo I; Maniatis AN
    Scand J Infect Dis; 2006; 38(3):213-6. PubMed ID: 16500785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic characterization of blaNDM-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar.
    Sugawara Y; Akeda Y; Sakamoto N; Takeuchi D; Motooka D; Nakamura S; Hagiya H; Yamamoto N; Nishi I; Yoshida H; Okada K; Zin KN; Aye MM; Tomono K; Hamada S
    PLoS One; 2017; 12(9):e0184720. PubMed ID: 28910381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.